42
Participants
Start Date
August 31, 2012
Primary Completion Date
May 31, 2014
Study Completion Date
September 30, 2014
EGCG+RSV-supplementation
Teavigo (\~300mg/d) Resveratrol (\~80mg/d)
Placebo
Maastricht University, Maastricht
Maastricht University Medical Center
OTHER